Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001209191-21-049114

Chief Medical Officer sold 15,000 shares at $45.00 ($675,000)

  • Chief Medical Officer acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Crystal Adam Chief Medical Officer 2021-07-29 Option exercise +15,000 $4.98 $74,700 15,000 D
Crystal Adam Chief Medical Officer 2021-07-29 Sale −15,000 $45.00 $675,000 0 D
Derivatives
Crystal Adam Chief Medical Officer 2021-07-29 Option exercise · Stock Option (Right to Buy) −15,000 183,108 D
Open-market sales · 15,000 sh · avg $45.00 · $675,000
Loading xslF345X03/doc4.xml…